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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S324and, in addition to its powerful antioxidant activity, it may exert mod-
ulatory effects on different signalling pathways.
Methods: The immortalized human cell line C-28/I2 and primary cul-
tures of human chondrocytes (prepared from fragments of articular
cartilage obtained from adult OA patients undergoing knee arthro-
plasty) were treated with HT, 30 minutes before exposition to hydrogen
peroxide to induce oxidative stress and samples were collected at dif-
ferent times. We tested cell viability through reading on MUSE Cell
Analyzer. The expression of genes and proteins known or potentially
implicated in OA was evaluated by Real-Time RT-PCR assay and by
Western blot method, respectively. By 6 different algorithms (TargetS-
can, miRanda, PICTAR4, miRDB, miRWalk, RNA22) bioinformatic anal-
ysis selected possible candidate microRNAs that could interact with
targets of interest. Subsequently we veriﬁed by Real Time RT-PCR assay
possible variations in the expression of these microRNAs after
treatments.
Results:We evaluated the gene expression of runt-related transcription
factor-2 and matrix metalloproteinase-13, two molecular markers of
OA, in human primary chondrocytes cultured in monolayer. HT pre-
vents the increase induced by oxidative stress in the mRNA amount of
bothmarkers. Moreover this compound is able to reduce signiﬁcantly C-
28/I2 cells death. In order to investigate a possible involvement of
autophagic process in this context, we evaluated the protein expression
of LC3 II (active form associated to autophagosomes), after oxidative
stress in presence or in absence of HT. We found that HT induces an
increase of protein levels of this autophagic marker, suggesting a pos-
sible mechanism of cytoprotection. This effect of HT on autophagy may
be promoted by modulating several effectors such as AMP-activated
protein kinase (AMPK) and the NAD-dependent deacetylase Sirtuin-1
(SIRT-1). Indeed HT causes the increase of phospho-AMPK and SIRT-1
protein levels. At the same time, this compound is able to decrease the
amount of microRNA-9, which can target SIRT-1mRNA thusmodulating
its expression.
Conclusions: This study suggests newmolecular mechanisms by which
HT may prevent some aspects of OA pathogenesis and progression.
Indeed the beneﬁcial action of HT in this context seems to be related to
the stimulation of autophagy. These data indicate that HT can be con-
sidered an attractive tool for the prevention of OA.This work was sup-
ported by FIRB (Ministero dell’istruzione, dell’Universita e della Ricerca,
Italy) grant RBAP10KCNS.
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EFFICACY AND SAFETY OF GINGER IN OSTEOARTHRITIS PATIENTS: A
SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED
PLACEBO-CONTROLLED TRIALS
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Purpose: To assess the clinical efﬁcacy and safety of oral ginger for
symptomatic treatment of osteoarthritis (OA).
Methods: A systematic literature search was undertaken in the biblio-
graphic databases: MEDLINE via PubMed from 1950, EMBASE via OVID
from 1980, CINAHL via EBSCO from 1981,Web of Science from 1900, and
Sciﬁnder from 1907, as well as The Cochrane Central Register of Con-
trolled Trials, all up to August 2013. Inclusion criteriawere: Randomized
trials comparing any oral ginger preparation (consisting only of extracts
of ginger species) with placebo, where the participants were aged 18 or
over with OA in any joint. Major outcomes were reduction in pain and
improvement in physical function. Harm was assessed as withdrawals
due to adverse events. The efﬁcacy effect size was estimated using
Hedges’ standardized mean difference (SMD) and safety using the risk
ratio (RR). Standard random-effects meta-analysis was used by default
(conﬁrmed by a ﬁxed-effects model), and inconsistency was evaluated
by the I-squared index (I2).
Results: Out of 113 retrieved references, 108 were discarded, leaving
ﬁve placebo-controlled trials (757 patients, mainly with knee and/or
hip OA) for the meta-analysis. The majority reported relevantrandomization procedures and blinding but applied an inadequate
intention-to-treat (ITT) approach. Pain reduction following ginger
intake revealed a low degree of heterogeneity among trials (I2 ¼ 27%),
with a statistically signiﬁcant SMD of -0.30 (95% CI: [-0.50, -0.09], P ¼
0.005) in favour of ginger. Ginger showed a statistically signiﬁcantly
larger improvement in physical function than placebo SMD¼ -0.22 (95%
CI: [-0.39, -0.04]; P¼ 0.01; I2¼ 0%). Based on data from three trials (328
patients), patients given ginger were more than twice as likely to dis-
continue treatment due to adverse events compared to placebo (RR ¼
2.33; 95% CI: [1.04, 5.22]; P ¼ 0.04; I2 ¼ 0%).
Conclusions: Ginger was found modestly efﬁcacious in reducing pain
and improve physical function in clinical trials of patients with mainly
knee and/or hip OA. Ginger was also reasonably safe since reported
adverse events were mild and reversible. We judged the evidence to be
of moderate quality, based on the small number of participants and
non-adequate ITT analysis (with the latter risk of bias item leading to
downgrading from high to moderate conﬁdence in the estimates).
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Purpose: Osteoarthritis (OA) is a signiﬁcant worldwide health problem
owing to the progressive and debilitating nature of the condition, which
results in highmorbidity and amarked decrease in the quality of life. OA
involves the progressive degeneration of articular cartilage with a
remodeling of subchondral bone and synovitis.
The objective is to evaluate the potential anti-arthritic activity of Acti-
Joint, a formulation that includes CS Bioactive (Chondroitin Sulfate
100% purity ,CS), Glucosamine (GLU) and Hyal-Joint, a natural ingre-
dient rich in sodium hyaluronate in an in vitro chondrocyte model and
in the collagen-induced arthritis (CIA) model in rats.
Methods: An in vitro study was performed using human osteoarthritic
chondrocytes cultured in alginate (n¼ 3) in order to evaluate the
potential chondroprotective activity of Acti-Joint. Effects on degra-
dation of the extracellular matrix were determined by measuring
metalloproteinase-1 (MMP-1) and metalloproteinase-13 (MMP-13)
activities by ELISA (R&D kits). The synthesis of sulfated glyco-
saminoglycans (GAGs) was measured in chondrocytes by determining
the incorporation of [35S]sulfate into cetylpyridiniumchloride-precip-
itable (CPC) GAGs by liquid scintillation analysis.
The anti-arthritic activity was investigated in the CIA model in rats.
Female rats with developing type II collagen arthritis (n ¼ 11) were
treated orally once daily with distilled water (Vehicle group) or Acti-
Joint (160 mg/kg) starting 10 days prior to disease induction through
the end of the study (day 35). Dexamethasone, the positive control
group, was administered once daily starting at day 0. The arthritic
clinical score for each animal was examined starting at day 7. A clinical
score was given to each individual paw and was based on 0-4 scale. The
sum of all paws was calculated for each animal. In addition, a cytokine
analysis on the left hind joint was performed: IL-6 and TNFa gene
expression.
Results: The in vitro assays showed that Acti-Joint leads to a stat-
istically signiﬁcant reduction of MMP-1 andMMP-13 activities (p<0.05)
and also a stimulation of the synthesis of GAGs compared to the Control.
Acti-Joint showed better efﬁcacy than the standard combination GLU
þ CS, being CS of a lower quality and uncertain traceability. In the
experimental conditions of the in vivo study, we found that this for-
mulation reduced about 10% the clinical score after 3 weeks of the
arthritis induction. This was accompanied by a signiﬁcant reduction of
the pro-inﬂammatory cytokines IL-6 (74%) and TNFa (70%) levels
compared to Vehicle group.
Conclusions: The present study indicates that Acti-Joint has chon-
droprotective and anti-inﬂammatory activities. Thus, this natural
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S325combination may be useful as a nutritional supplement for osteo-
arthritis treatment.
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EFFECTS OF A LOW-FAT YOGURT SUPPLEMENTED WITH A ROOSTER
COMB EXTRACT (MOBILEE) ON JOINT FUNCTION IN ADULTS WITH
MILD KNEE PAIN: A RANDOMIZED TRIAL
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Knee osteoarthritis (OA) is one of major public health problem and a
cause of chronic disability in senior population. One of the recognized
risk factors for OA is the weakness of the knee ﬂexor and extensor
muscles.
Purpose: The aim of this study was to assess the effects of a low-fat
dairy product supplemented with rooster comb extract (RCE), a natural
extract rich in hyaluronic acid (HA), on muscle function and echo-
graphic evolution of patients with mild knee pain.
Methods: 80 participants (30 men) aged (mean SD) 43.10  15 years,
with mild knee pain (Visual Analogic Scale between 30 and 50 mm),
were included in a randomized, controlled, double-blind, parallel
intervention trial: 40 participants received a low-fat yogurt (125 mL/d)
with 80 mg/d of RCE presented as Mobilee and 40 participants con-
sumed the same low-fat yogurt without RCE (125 mL/d (the control
group) during 3 months. The knee muscle strength was determined in
ﬂexion and extension at 180/s and 240/s speeds using an isokinetic
dynamometer Biodex System 4. Synovial effusion was measured by
ultrasonography and pain was assessed by Visual Analogic Scale (VAS).
Results: At 3 months, an increase of the muscle strength of the affected
joint was detected in ﬂexion and extension at 180/s and 240/s in the
RCE group as compared to baseline in men and particularly in people
older than 50 (p¼0.032), while no differences were detected in the
control group. Synovial effusion was reduced by 2.4% in the RCE group
and increased by 3.93% in the control group, but differences failed to
reach statistical signiﬁcance. No differences on VAS pain were detected
during the studied period.
Conclusions: A long-term intake of a low-fat yogurt supplemented
with RCE increases muscle strength suggesting better performance of
the quadriceps and hamstring muscles on the knee pain, in men,
especially in people of 50 years, thus provide new dietary therapeutic
perspectives.
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Purpose: Collagen hydrolysates (CHs) are popular nutriceuticals used
for prophylaxis and treatment of osteoarthritis (OA). Pharmacokinetic
studies with mice showed that orally administered radioactive CH is
resorbed and some radioactivity is recovered within joints. CHs were
found to stimulate the biosynthesis of collagen when testing cultured
bovine chondrocytes. However, studying collagen type II fragments
isolated from human cartilage, increased matrix degradation was dis-
covered which might either contribute to cartilage destruction or be
just a normal endogenous metabolic feedback. A ligand-receptor
interaction of small collagen fragments with the a2A domain of integrin
might serve as a molecular mode of action of CH (St€otzel et al. 2012).
Recently, signiﬁcant differences in the composition of peptides as well
as efﬁcacy of bovine CHs on human chondrocytes were reported. The
aim of our current study was to characterize for the ﬁrst time com-
mercially available CHs obtained from ﬁsh with respect to their
molecular composition and pharmacological effects on the metabolism
of human articular OA cartilage.
Methods:MALDI-TOF mass spectrometry was applied to determine the
molecular weight (Mr) distribution of CHs from ﬁsh (Peptan F 5000;Peptan F 2000 from Rousselot). DOSY, TOCSY and NOESY NMR
measurements were carried out to further characterize the CHs. Before
starting the experiments with tissues from human patients, approval by
the ethical board of our university and the written informed consent of
the patients were obtained. Full-thickness cartilage explants of femoral
condyles were obtained from OA patients undergoing knee replace-
ment surgery. Articular cartilage explants with mild or moderate OA
alterations were cultured in serum-free Ham’s F12 media together with
the serum substitute CR-ITSþ in a normal benchtop CO2-incubator.
Explants were double radiolabeled with [3H]-proline, washed several
times, and then radiolabeled againwith [14C]-proline in the presence of
0-10 mg/ml CHs (Goodwin et al. 2008). At the end of the experiments,
media and explants were frozen at -20oC in the presence of proteinase
inhibitors until analysis. Proteoglycans were determined by the DMMB-
method, NO by the Griess reaction, whereas MMP-1, -3, -13 and colla-
gen type II within media were measured using ELISA kits. Cell viability
was evaluated microscopically using ﬂuorescein diacetate and propi-
dium iodide. Untreated explants served as controls. Data presented are
mean  SD (n¼6). Groups of data were evaluated using ANOVA and the
Friedman test. Signiﬁcance was set to p < 0.05.
Results: Mass spectrometry revealed a two fold larger Mr distribution
of peptides obtained from Peptan F 5000 compared with Peptan F
2000. The average Mr was 3600 kDa for Peptan F 5000 and 2900 kDa
for Peptan F 2000. According to the DOSY NMR experiments both
Peptan probes also contain larger fragments. With the TOCSY and
NOESY NMR measurements, we can discriminate between certain col-
lagen fragments in each CH preparation thereby characterizing them in
respect to their potential bioactivity. None of the CHs tested displayed
any stimulatory effect on the biosynthesis of collagen. Only Peptan F
2000 induced an elevated level of NO. None of the investigated CHs
induced an increased loss of collagen even though signiﬁcantly elevated
levels of MMP-1, -3, -13 and/or PGE2 were found for Peptan F 5000.
Both CHs tested at the high concentration of 10mg/ml are not cytotoxic.
Conclusion: Our investigation show for the ﬁrst time that ﬁsh CH
preparations differ considerably with respect to both their composition
of hydrolyzed peptides and their biological activities on human chon-
drocytes. Thus, the pharmacological properties of commercially avail-
able CHs should be tested thoroughly both in vitro and in vivo to
provide scientiﬁcally ﬁrm statements concerning safety and efﬁcacy in
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NATURAL HISTORY OF INTRAMENISCAL SIGNAL ON MAGNET
RESONANCE IMAGING: A COHORT STUDY OVER 6 YEARS WITH
ASSESSMENT AT 4 TIME POINTS USING DATA FROM THE
OSTEOARTHRITIS INITIATIVE
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Purpose: To assess the natural history of intrameniscal signal in the
medial compartment. We hypothesized that 1) linear intrameniscal
signal rarely resolves. 2) menisci with linear intrameniscal signal are
more likely to develop a meniscal tear over time.
Methods: We studied both knees from 192 subjects aged 45-55 years
randomly drawn from the Osteoarthritis Initiative participants free of
evidence of radiographic knee osteoarthritis (OA) (Kellgren Lawrence
grade¼0 in both knees). Subjects were also free of medial meniscal tear
on MRI at baseline in both knees. We assessed coronal intermediate-
weighted (IW) and sagittal IW fat saturated 3-Tesla magnetic resonance
images from baseline and the 24-, 48-, and 72-month follow-up of
subjects’ both knees. One radiologist, unblinded to time sequence and
with paired images, scored medial meniscal integrity in the anterior
horn, body, and posterior horn, respectively. Hence, the reader recorded
the presence of intrameniscal signal (grade 0¼none; 1¼one or several
punctuate or globular intensities; 2¼linear but not reaching surface;
3¼linear but reaching surface on one slice only), meniscal tear, and
meniscal maceration/destruction. We classiﬁed abnormal signal as
meniscal tear when signal extended to surface on at least two consec-
utive images, and considered linear intrameniscal signal to be present if
graded 2 or 3. We used the logistic mixed effect model to evaluate the
